Keegan B Mark, Pittock Sean J, Lennon Vanda A
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Ann Neurol. 2008 Apr;63(4):531-4. doi: 10.1002/ana.21324.
Several autoimmune myelopathies are recognized clinically. We describe 57 patients in whom serological evaluation for myelopathy of uncertain cause demonstrated collapsin response-mediator protein 5 IgG. Most had spinal imaging and cerebrospinal fluid abnormalities and insidiously progressive presentation; some had acute monophasic or relapsing myelopathy. Initial diagnoses included multiple sclerosis, transverse myelitis, and unspecified neurodegenerative myelopathy. Most were smokers; neoplasia was discovered in 68% (most commonly small-cell lung carcinoma and after collapsin response-mediator protein-5 IgG detection). Collapsin response-mediator protein-5 autoimmune myelopathy and occult neoplasia are important considerations in patients with insidiously progressive myelopathy, especially with known cancer risk.
临床上已认识到几种自身免疫性脊髓病。我们描述了57例病因不明的脊髓病患者,其血清学评估显示存在塌陷反应介导蛋白5 IgG。大多数患者有脊髓影像学和脑脊液异常,起病隐匿且呈进行性;部分患者有急性单相或复发性脊髓病。初始诊断包括多发性硬化、横贯性脊髓炎和未明确的神经退行性脊髓病。大多数患者为吸烟者;68%的患者发现有肿瘤(最常见的是小细胞肺癌,且在塌陷反应介导蛋白-5 IgG检测之后发现)。塌陷反应介导蛋白-5自身免疫性脊髓病和隐匿性肿瘤是隐匿性进行性脊髓病患者的重要考虑因素,尤其是有已知癌症风险的患者。